General Information
Biodel DM2 3-250
A Randomized, open-label group Phase 2b trial evaluating safety and efficacy of BIOD-531 compared Humalog Mix 75/25 in subjects with type 2 diabetes.
| Protocol | 3-250 |
|---|---|
| Identifier | 3-250 Site Number: 009 |
| UID | a2c29fd4-3c68-4bf0-a5eb-3c3a3e6bb58e |
| Status | Cancelled |
| Phase | 2b |
| Category | Diabetes Type 2 / Adult |
| Launch Year | 2015 |
| NCT Number | - |
| Created | 2015-03-26 12:22 |
| Last Updated | 2015-03-26 12:22 |
Description
No description provided.
Comment
No comment.
Target Dates
| Name | Date | Required |
|---|---|---|
| Enrollment Closed | No | |
| Enrollment Open | No | |
| First Patient First Visit | No | |
| Site Initiation Mtg. | 2015-05-20 | No |
| PI Meeting Start | No | |
| PI Meeting End | No | |
| PI Meeting Arrival | No | |
| PI Meeting Departure | No | |
| Closeout Date | 2016-01-29 | No |
| Final PatientVisit | No | |
| PreStudy Selection Visit | No | |
| Target Date 12 | No | |
| Target Date 13 | No | |
| Target Date 14 | No |
Leadership
| Role | Staff | Login | Required |
|---|---|---|---|
| Principal | Martinez, Gilbert | GJMartinez | No |
| Recruiter | - | No | |
| Coordinator | Barnett, Omar | OBarnett | No |
| Regulatory | Aguirre, Sandra | SAguirre | No |
Custom Fields
No custom fields.
Sponsor & Organization
| Sponsor | Biodel, Inc. |
|---|---|
| Division | Biodel, Inc. |
| Team | Biodel, Inc. |
| Managing Site | Catalina Research Institute, LLC |
| Organization |
Contacts
| IRB Ref | |
|---|---|
| CRO | Covance -LabCorp Drug Development |
| CRO Ref | |
| Correspondence | 0 |
Opportunity
| Probability | 0 |
|---|---|
| Comment | |
| Status Color | Yellow |
| Currency | - |
